The suppressor-cell network in cancer (second of two parts).
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000032:analysis; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007167:Immunotherapy; D007938:Leukemia / Q000276:immunology; D008223:Lymphoma / Q000276:immunology; D008285:Major Histocompatibility Complex; D051379:Mice; D009362:Neoplasm Metastasis / Q000276:immunology; D009369:Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D009374:Neoplasms, Experimental / Q000276:immunology; D011817:Rabbits; D013601:T-Lymphocytes / Q000276:immunology*
D007106:Immune Sera; D007136:Immunoglobulins